| Marissa Naomi Karpoff, MD | |
|
1935 Route 70 E Fl 2, Cherry Hill, NJ 08003 | |
| (856) 428-7700 | |
| Not Available |
| Full Name | Marissa Naomi Karpoff |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 11 Years |
| Location | 1935 Route 70 E Fl 2, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659613347 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 277829 (New York) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 25MA10574700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmc Department Of Medicine Group Pa | 2163335878 | 329 |
News Archive
While the onset of inflammatory bowel disease (ulcerative colitis or Crohn's disease) in adulthood is tied to a higher mortality, the actual number of deaths has been falling, a Swedish study from Karolinska Institutet published in the journal Gut reports.
Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.
GHX today announced the market segment winners of the seventh annual Best-in-Class Awards, recognizing medical-surgical manufacturers that achieved the top-share position in six specific markets: Hospital, Long-Term Care, Treatment Centers, Home Health Care, Physician Office and Clinical Laboratory, which is a new category this year.
New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute.
› Verified 3 days ago
| Entity Name | Cmc Department Of Medicine Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386682094 PECOS PAC ID: 2163335878 Enrollment ID: O20050104000343 |
News Archive
While the onset of inflammatory bowel disease (ulcerative colitis or Crohn's disease) in adulthood is tied to a higher mortality, the actual number of deaths has been falling, a Swedish study from Karolinska Institutet published in the journal Gut reports.
Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.
GHX today announced the market segment winners of the seventh annual Best-in-Class Awards, recognizing medical-surgical manufacturers that achieved the top-share position in six specific markets: Hospital, Long-Term Care, Treatment Centers, Home Health Care, Physician Office and Clinical Laboratory, which is a new category this year.
New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marissa Naomi Karpoff, MD 1 Federal St # 200, Camden, NJ 08103-1088 Ph: (856) 356-4924 | Marissa Naomi Karpoff, MD 1935 Route 70 E Fl 2, Cherry Hill, NJ 08003 Ph: (856) 428-7700 |
News Archive
While the onset of inflammatory bowel disease (ulcerative colitis or Crohn's disease) in adulthood is tied to a higher mortality, the actual number of deaths has been falling, a Swedish study from Karolinska Institutet published in the journal Gut reports.
Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.
GHX today announced the market segment winners of the seventh annual Best-in-Class Awards, recognizing medical-surgical manufacturers that achieved the top-share position in six specific markets: Hospital, Long-Term Care, Treatment Centers, Home Health Care, Physician Office and Clinical Laboratory, which is a new category this year.
New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute.
› Verified 3 days ago
Shagufta Ahsan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003 Phone: 917-808-5942 | |
Dr. Alexandr Zaslavsky, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-406-0023 | |
Dr. Tolulope Adesiyun Agunbiade, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034 Phone: 856-482-8900 | |
Garo Charles Avetian, D.O. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003 Phone: 856-761-8100 Fax: 856-761-8107 | |
Matthew Everwine, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-513-4124 | |
Dr. Behjath Jafry, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034 Phone: 856-428-6616 Fax: 856-428-4823 | |
William C Groh, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034 Phone: 856-216-0300 |